Jan Novák

Jan Novák

Auto-generated profile, based on publicly available information

Jan Novák

Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 1994 in Journal of Chromatography B: Biomedical Sciences and Applications
Verified
Journal Article
Closed access
JSJ. Suttnar
J. Suttnar
JDJ.E. Dyr
J.E. Dyr
EHE. Hamšíková
E. Hamšíková
JNJ. Novák
J. Novák
VVV. Vonka
V. Vonka

1 June 1991 in Journal of General Virology
Verified
Journal Article
Open access
PDF file
JNJan Novák
Jan Novák
PSPavel Sova
Pavel Sova
VKViktor Krchnak
Viktor Krchnak
EHEva Hamšíková
Eva Hamšíková
HZHana Závadová
Hana Závadová
JRJaroslav Roubal
Jaroslav Roubal
The entire amino acid sequence of human cytomegalo-virus (HCMV) 150K matrix phosphoprotein (pp150), consisting of 1048 amino acid residues, was divided into 95 overlapping 20 amino acid peptides which were synthesized on polyethylene rods. The rods were subjected to ELISA with pooled anti-HCMV-positive and anti-HCMV-negative sera. Four peptides recognized by the anti-HCMV-positive pool only were synthesized by the solid-phase method and their reactivity in a conventional ELISA, using a panel of 14 individual anti-HCMV-negative and 20 anti-HCMV-positive antisera, was evaluated; three peptides were found to be specifically reactive. Results obtained with one of these peptides (residues 595 to 614) in ELISA showed a good correlation with those obtained using a routinely performed complement fixation test.

1 January 2017 in Acta Parasitologica
Verified
Journal Article
Closed access
PDF file
JNJan Novák
Jan Novák
LPLucie Panská
Lucie Panská
TMTomáš Macháček
Tomáš Macháček
LKLibuše Kolářová
Libuše Kolářová
Petr HorákPetr Horák
Petr Horák

28 February 1994 in Immunology Letters
Verified
Journal Article
Closed access
JTJaroslav Turánek
Jaroslav Turánek
MTMiroslav Toman
Miroslav Toman
JNJan Novák
Jan Novák
VKViktor Krchnak
Viktor Krchnak
PHPavla Hořavová
Pavla Hořavová

2 September 2022 in Parasitology
Verified
Journal Article
Closed access
PDF file
JNJan Novák
Jan Novák
TMTomáš Macháček
Tomáš Macháček
MMMartin Majer
Martin Majer
MKMarie Kostelanská
Marie Kostelanská
KSKateřina Skulinová
Kateřina Skulinová
PHPetr Horák
Petr Horák
Toxocara canis, a gastrointestinal parasite of canids, is also highly prevalent in many paratenic hosts, such as mice and humans. As with many other helminths, the infection is associated with immunomodulatory effects, which could affect other inflammatory conditions including autoimmune and allergic diseases. Here, we investigated the effect ofT. canisinfection on the course of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis. Mice infected with 2 doses of 100T. canisL3 larvae 5 weeks prior to EAE induction (theTc+EAE group) showed higher EAE clinical scores and greater weight loss compared to the non-infected group with induced EAE (the EAE group). Elevated concentrations of all measured serum cytokines (IL-1α, IL-2, IL-4, IL-6, IL-10, IL-17A, IFN-γand TNF-α) were observed in theTc+EAE group compared to the EAE group. In the CNS, the similar number of regulatory T cells (Tregs; CD4+FoxP3+Helios+) but their decreased proportion from total CD4+ cells was found in theTc+EAE group compared to the EAE group. This could indicate that the groupTc+EAE harboured significantly more CD4+ T cells of non-Treg phenotype within the affected CNS. Altogether, our results demonstrate that infection of mice withT. canisworsens the course of subsequently induced EAE. Further studies are, therefore, urgently needed to reveal the underlying pathological mechanisms and to investigate possible risks for the human population, in which exposure toT. canisis frequent.

9 April 2025 in Parasite
Verified
Journal Article
Open access
PDF file
OVOndřej Vosála
Ondřej Vosála
BŠBarbora Šmídová
Barbora Šmídová
JNJan Novák
Jan Novák
JSJan Svoboda
Jan Svoboda
TPTomas Petrasek
Tomas Petrasek
TMTomáš Macháček
Tomáš Macháček
The potential link between the infections and the development of Alzheimer’s disease (AD) has led to speculations about the role of various pathogens in triggering amyloid-β (Aβ) overproduction, possibly leading to AD onset. The globally distributed dog roundworm Toxocara canis was suggested to be a suitable candidate due to neurotropism of the larvae and infection chronicity. This study investigated whether chronic T. canis infection induces AD-like pathology in mice and whether Aβ is toxic to T. canis. BALB/c and APP/PS1 transgenic mice, which overproduce Aβ, were infected with T. canis L3 larvae and monitored for larval burden, Aβ accumulation, and behavioral changes. In vitro tests of recombinant Aβ toxicity against the larvae were also performed. Despite the presence of T. canis larvae in the central nervous system 8 and 16 weeks post-infection, no significant increase in Aβ concentration or AD-related behavioral alterations were observed. Aβ was detected on the surface and within the intestines of T. canis larvae, but in vitro exposure to recombinant Aβ did not affect larval viability or morphology. Our findings suggest that T. canis infection does not trigger AD-like pathology in mice, and Aβ does not act as an antiparasitic agent. This challenges the emerging hypothesis that chronic neurotoxocarosis infections may contribute to AD development.